References
- Reddy P , BociK, CharbonneauC. The epidemiologic, health-related quality of life, and economic burden of gastrointestinal stromal tumours. J. Clin. Pharm. Ther.32(6), 557–565 (2007).
- Fero KE , CoeTM, FantaPT, TangCM, MurphyJD, SicklickJK. Surgical management of adolescents and young adults with gastrointestinal stromal tumors: a US population-based analysis. JAMA Surg.152(5), 443–451 (2017).
- Nilsson B , BümmingP, Meis-KindblomJMet al. Gastrointestinal stromal tumors: the incidence, prevalence, clinical course, and prognostication in the preimatinib mesylate era – a population-based study in western Sweden. Cancer103(4), 821–829 (2005).
- Yan L , ZouL, ZhaoWet al. Clinicopathological significance of c-kit mutation in gastrointestinal stromal tumors: a systematic review and meta-analysis. Sci. Rep.5, 13718 (2015).
- Cameron S , BehamA, SchildhausHU. Current standard and future perspectives in the treatment of gastrointestinal stromal tumors. Digestion95(4), 262–268 (2017).
- Poveda A , Garcia Del MuroX, Lopez-GuerreroJAet al. GEIS guidelines for gastrointestinal sarcomas (GIST). Cancer Treat. Rev.55, 107–119 (2017).
- Abdel-Rahman O , FouadM. Systemic therapy options for advanced gastrointestinal stromal tumors beyond first-line imatinib: a systematic review. Future Oncol.11(12), 1829–1843 (2015).
- Miettinen M , LasotaJ. Gastrointestinal stromal tumors: review on morphology, molecular pathology, prognosis, and differential diagnosis. Arch. Pathol. Lab. Med.130(10), 1466–1478 (2006).
- Rutkowski P , WozniakA, Debiec-RychterMet al. Clinical utility of the new American Joint Committee on Cancer staging system for gastrointestinal stromal tumors: current overall survival after primary tumor resection. Cancer117(21), 4916–4924 (2011).
- Tanimine N , TanabeK, SuzukiT, TokumotoN, OhdanH. Prognostic criteria in patients with gastrointestinal stromal tumors: a single center experience retrospective analysis. World J. Surg. Oncol.10(1), 43 (2012).
- Surveillance, Epidemiology, and End Results (SEER) Program SEER*Stat database: incidence – SEER 18 Regs Research Data+Hurricane Katrina Impacted Louisiana Cases, Nov 2016 Sub (1973–2014 varying) – Linked To County Attributes – Total US, 1969–2015 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, Surveillance Systems Branch, released April 2017, based on the November 2016 submission.
- Corless CL , FletcherJA, HeinrichMC. Biology of gastrointestinal stromal tumors. J. Clin. Oncol.22(18), 3813–3825 (2004).
- Soreide K , SandvikOM, SoreideJA, GiljacaV, JureckovaA, BulusuVR. Global epidemiology of gastrointestinal stromal tumours (GIST): a systematic review of population-based cohort studies. Cancer Epidemiol.40, 39–46 (2016).
- Miettinen M , LasotaJ. Gastrointestinal stromal tumors: pathology and prognosis at different sites. Semin. Diagn. Pathol.23(2), 70–83 (2006).
- Oweira H , PetrauschU, HelblingDet al. Prognostic value of site-specific extra-hepatic disease in hepatocellular carcinoma: a SEER database analysis. Expert Rev. Gastroenterol. Hepatol.11, 695–701 (2017).
- Oweira H , PetrauschU, HelblingDet al. Prognostic value of site-specific metastases in pancreatic adenocarcinoma: a Surveillance Epidemiology and End Results database analysis. World J. Gastroenterol.23(10), 1872–1880 (2017).
- Abdel-Rahman O . Assessment of the prognostic and discriminating value of the novel bioscore system for breast cancer; a SEER database analysis. Breast Cancer Res. Treat.164(1), 231–236 (2017).
- Kemmerling R , WeylandD, KiesslichTet al. Robust linear regression model of Ki-67 for mitotic rate in gastrointestinal stromal tumors. Oncol. Lett.7(3), 745–749 (2014).
- Guller U , TarantinoI, CernyT, UlrichA, SchmiedBM, WarschkowR. Revisiting a dogma: similar survival of patients with small bowel and gastric GIST. A population-based propensity score SEER analysis. Gastric Cancer20(1), 49–60 (2017).
- Kim M-C , YookJ-H, YangH-Ket al. Long-term surgical outcome of 1057 gastric GISTs according to 7th UICC/AJCC TNM system: multicenter observational study from Korea and Japan. Medicine94(41), e1526 (2015).
- Schmieder M , Henne-BrunsD, MayerBet al. Comparison of different risk classification systems in 558 patients with gastrointestinal stromal tumors after r0-resection. Front. Pharmacol.7, 504 (2016).